UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                  FORM 10-QSB

                                   (Mark  One)
  [X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
                                     OF 1934

                For the six month period ended September 30, 2000
                                               ------------------

  [ ]  TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  EXCHANGE ACT

              For the period from ______________ to ______________

                        Commission file number    0-26445
                                                  -------


                        ACCESS HEALTH ALTERNATIVES, INC.
                        --------------------------------
        (Exact name of small business issuer as specified in its charter)


                 Florida                             59-3542362
                 -------                             ----------
           (State of other jurisdiction              (IRS Employer
        of incorporation or organization)            Identification No.)


                 4619 Parkbreeze Court, Orlando, Florida  32808
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (407)  299-0629
                                 ---------------
                           (Issuer's Telephone Number)


--------------------------------------------------------------------------------
   (Former name, former address and former fiscal year, if changed since last
                                     report)


                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check  whether  the  registrant  filed  all documents and reports required to be
filed  by  Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities  under  a  plan  confirmed  by  a  court.  Yes  [  ]  No  [  ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.  There are 3,158,275 shares of common
stock  as  of  September  30,  2000.
               --------------------

Transitional  Small  Business  Disclosure  Format  (Check  one)  Yes [ ]  No [X]

                         PART I - FINANCIAL INFORMATION


<PAGE>
<TABLE>
<CAPTION>
                                 ACCESS HEALTH ALTERNATIVES, INC.

                                    CONSOLIDATED BALANCE SHEET

                                           (UNAUDITED)
                                                                   SEPTEMBER 30,     DECEMBER 31,
                                                                       2000             1999
                                                                  ---------------  --------------
<S>                                                               <C>              <C>
                                 ASSETS
                                 ------
Current assets:
  Cash                                                            $        2,858   $       1,757
  Receivables:
    Trade, net                                                            72,675          58,923
    Other                                                                  4,380           4,380
                                                                  ---------------  --------------

    Total receivables                                                     77,054          63,303
  Inventories                                                            114,282         144,250
                                                                  ---------------  --------------

    Total current assets                                                 194,194         209,310

Property and equipment, net                                               36,441          52,357
Other assets                                                               5,051           5,050
Deferred recission costs                                                 640,663         640,663
                                                                  ---------------  --------------

    Total assets                                                  $      876,349   $     907,380
                                                                  ===============  ==============

                LIABILITIES AND STOCKHOLDER'S DEFICIT
                -------------------------------------
Current liabilities:
  Notes and commercial paper                                      $    1,617,128   $   1,491,348
  Current obligation under capital lease                                   6,561           8,847
  Bank overdraft                                                          14,763           8,016
  Accounts payable                                                       473,085         404,935
  Accrued liabilities                                                    938,424         610,511
  Due to related parties:
    Stockholders                                                         158,159         185,137
    Limited liability companies including recision                     1,603,809       1,603,809
      of $763,750 to be offered to holders of economic
      interests at September 30, 1999
    Access Healthcare, Inc.                                              164,187          29,651
                                                                  ---------------  --------------

        Total due to related parties                                   1,926,155       1,818,597
                                                                  ---------------  --------------

        Total current liabilities                                      4,976,117       4,342,254

Unearned income                                                          196,694         274,370
Obligation under capital lease, less current portion                      12,594          10,749
Minority interest in subsidiary                                          129,545         129,545
                                                                  ---------------  --------------

        Total liabilities                                              5,314,950       4,756,918

Stockholders' deficit:
  Preferred stock, $.01 par value, 10,000,000 shares authorized,               -               -
    none issued
  Common stock, $.001 par value, 50,000,000 shares authorized,
    3,158,275 shares issued and outstanding                                3,158           2,627
  Capital in excess of par value                                       1,779,691       1,530,217
  Accumulated deficit                                                 (6,221,450)     (5,382,382)
                                                                  ---------------  --------------

        Total stockholders' deficit                                   (4,438,601)     (3,849,538)
                                                                  ---------------  --------------

        Total liabilities and stockholders' deficit               $      876,349   $     907,380
                                                                  ===============  ==============
</TABLE>

See accompanying notes to consolidated financial statements.


<PAGE>
<TABLE>
<CAPTION>
                           ACCESS HEALTH ALTERNATIVES, INC.

                         CONSOLIDATED STATEMENT OF OPERATIONS

                                     (UNAUDITED)

                                      THREE MONTHS ENDED        NINE MONTHS ENDED
                                          SEPTEMBER 30,           SEPTEMBER 30,
                                        2000        1999        2000         1999
                                     ----------  ----------  ----------  ------------
<S>                                  <C>         <C>         <C>         <C>
Revenues:
  Equipment                          $       -   $       -   $       -   $         -
  Products                              39,019     161,550     138,420       362,175
  Other                                 19,000      49,164      57,702       184,408
                                     ----------  ----------  ----------  ------------

    Total revenues                      58,019     210,714     196,122       546,583

Cost of sales:
  Equipment                                  -           -           -             -
  Products                               6,888      17,246      29,968        94,360
  Other                                      -           -           -         2,460
                                     ----------  ----------  ----------  ------------

      Total cost of sales                6,888      17,246      29,968        96,820
                                     ----------  ----------  ----------  ------------

      Gross profit                      51,131     193,468     166,154       449,763

Selling, general and administrative    228,443     539,894     818,206     1,365,633
                                     ----------  ----------  ----------  ------------

      Operating loss                  (177,312)   (346,426)   (652,053)     (915,870)

Other expense:
  Interest expense                     136,382      55,389     185,463       104,764
  Other, net                               121           -       1,552             -
                                     ----------  ----------  ----------  ------------

      Total other expense              136,503      55,389     187,015       104,764
                                     ----------  ----------  ----------  ------------

      Net loss                       $(313,815)  $(401,815)  $(839,068)  $(1,020,634)
                                     ==========  ==========  ==========  ============

Basic net loss per share             $   (0.10)  $   (0.24)  $   (0.27)  $     (0.70)
***                                  ==========  ==========  ==========  ============
</TABLE>

See accompanying notes to consolidated financial statements.


<PAGE>
<TABLE>
<CAPTION>
                                     ACCESS HEALTH ALTERNATIVES, INC.
                                   CONSOLIDATED STATEMENT OF CASH FLOWS

                                               (UNAUDITED)

                                                           THREE MONTHS ENDED       NINE MONTHS ENDED
                                                              SEPTEMBER 30,            SEPTEMBER 30,
                                                            2000        1999        2000         1999
                                                         ----------  ----------  ----------  ------------
<S>                                                      <C>         <C>         <C>         <C>
Cash flows from operating activities:
  Net loss                                               $(313,815)  $(401,815)  $(839,068)  $(1,020,634)
  Adjustment to reconcile net loss to net cash provided
    by (used in) operating activities:
      Depreciation and amortization                          7,958       9,174      15,916        27,521
      Losses of limited liability companies                      -      92,482           -       178,686
      Unearned income recognized                           (38,676)    (19,500)    (77,676)      (58,500)
      Issuance of common stock for services                145,005     180,000     145,005       406,280
      Cash provided by (used in) changes in:
        Receivables                                         (8,477)    (73,853)    (13,751)      (95,103)
        Inventories                                          6,888       1,366      29,968        14,529
        Other assets                                             0       9,927           0          (979)
        Bank overdraft                                      11,412      32,725       6,747       (68,632)
        Accounts payable                                    (3,291)     47,495      68,150       (91,386)
        Accrued liabilities                                (41,789)     45,038     327,913       125,189
                                                         ----------  ----------  ----------  ------------

        Net cash used in operating activities             (234,785)    (76,961)   (336,795)     (583,029)

Cash flows from investing activities:
  Purchases of property and equipment                           (0)     (1,194)         (0)       (9,132)
                                                         ----------  ----------  ----------  ------------

Cash flows from financing activities:
  Payments on notes and commercial paper                         -     (31,026)          -      (165,013)
  Proceeds from notes and commercial paper                  43,277     199,999     125,780       644,428
  Due to stockholders                                      (24,928)      3,001     (26,979)      (91,669)
  Advances (to) from limited liability companies                 -    (147,575)          -      (254,264)
  Due to related party                                     109,557      (8,637)    134,536        (8,276)
  Payments on capital lease obligations                      2,493           -        (441)            -
  Proceeds from issuance of stock                          105,000           -     105,000       485,000
                                                         ----------  ----------  ----------  ------------

        Net cash provided by financing activities          235,400      15,762     337,897       610,206
                                                         ----------  ----------  ----------  ------------

  Net (decrease) increase in cash                              615     (62,393)      1,101        18,045

    Cash at beginning of period                              2,242      80,857       1,757           419
                                                         ----------  ----------  ----------  ------------

    Cash at end of period                                $   2,857   $  18,464   $   2,858   $    18,464
                                                         ==========  ==========  ==========  ============
Supplemental disclosure:
  Cash paid during the period for interest               $   2,250   $  55,389   $  11,660   $    91,871
                                                         ==========  ==========  ==========  ============
</TABLE>

See accompanying notes to consolidated financial statements.


<PAGE>
                        ACCESS HEALTH ALTERNATIVES, INC.

                  Notes to Consolidated Financial Statements

(1)  ORGANIZATION

     On September 2, 1998, Access HealthMax Holdings,  Inc. ("Holdings"),  f/k/a
     PLC Ventures Corp. ("PLC") acquired  approximately 94.3% of the outstanding
     common stock of Access HealthMax, Inc. ("HealthMax"), for 565,100 shares of
     authorized, but previously unissued common stock. Immediately preceding the
     exchange,  there were 437,500 shares  outstanding of PLC. The shares of PLC
     had been issued for a total  consideration  of $1,000.  PLC had no sales or
     revenues since its formation on October 2, 1988 and had zero  stockholders'
     equity at the time of  acquisition of HealthMax.  For accounting  purposes,
     the  acquisition has been treated as an acquisition of PLC by HealthMax and
     as a recapitilization  ("Reverse Acquisition") of HealthMax. The historical
     financial statements prior to September 2, 1998 are those of HealthMax. Pro
     forma   information   is  not  presented,   since  the   combination  is  a
     recapitilization rather than a business combination.  The deficiency in the
     net  assets  of PLC were  not  adjusted  in  connection  with  the  Reverse
     Acquisition since it consisted of accounts payable.

     On March 11, 1999, Holdings changed its name to Access Health Alternatives,
     Inc. ("Alternatives").  Unless the context indicates otherwise,  references
     hereinafter to the "Company" include HealthMax and/or Alternatives.

     On March 3, 1999, the Board of Directors  authorized a one-for-ten  reverse
     stock split  effective  March 15, 1999.  All  references  in the  financial
     statements to number of shares,  per share amounts and market prices of the
     Company's  common  stock have been  retroactively  restated  to reflect the
     decreased number of common shares outstanding.


(2)  BASIS  OF  PRESENTATION

     In  the  opinion  of  management,   the  accompanying   unaudited   interim
     consolidated  financial  statements  include all  adjustments  necessary to
     present  fairly the financial  position of the Company,  the results of its
     operations  and  cash  flows  for  the  interim  periods  reported.   These
     adjustments are of a normal  recurring  nature.  However,  the accompanying
     unaudited interim  consolidated  financial statements have been prepared in
     accordance  with the  instructions  and  requirements  of Form  10-QSB  and
     Regulation S-B and, therefore, do not include all information and footnotes
     for a fair  presentation of financial  position,  results of operations and
     cash flows in conformity with generally accepted accounting principles.

     The balance  sheet as of December  31,  1999,  was derived from the audited
     consolidated  balance sheet. These statements should be read in conjunction
     with the financial  statements  included in the Company's Form 10-KSB filed
     with  the  Securities  and  Exchange  Commission,   which  include  audited
     financial  statements  for the year ended December 31, 1999. The results of
     operations for the interim periods presented are not necessarily indicative
     of the results that may be expected for the year.


<PAGE>
(3)  LITIGATION

     In October,  1999 HealthMax was advised by the  Department of  Professional
     and Financial  Regulation,  Bureau of Banking,  Securities Division for the
     State of Maine that  certain  sales of LLC's  economic  interests  to Maine
     residents  were not covered by an  exemption  from  registration,  and were
     effected with the assistance of a person not licensed to sell securities in
     that state, and therefore are subject to rescission to the Maine investors,
     but has not yet determined the manner or method of this offer.  Neither the
     LLC's,  HealthMax nor the Company has sufficient  funds available to return
     the full amount of the Maine investors' interests  ($763,750),  should they
     all elect to rescind their investment. The Company has recorded a liability
     previously  recorded  with  respect  to the  state  of Maine  investors  of
     $640,663. The Company has recorded deferred rescission costs for $640,663.

     In  December   1999,  the  Company  became  aware  of  an  inquiry  by  the
     Comptroller's  office  of the  State of  Florida  into the  manner by which
     certain LLC  interests  were sold to  residents  of Florida.  The State has
     requested  certain  documents and information from the Company,  from LLC's
     and from  HealthMax in what the Company  believes is an effort to determine
     if securities  were sold without  registration or without an exemption from
     registration,  or by persons not licensed to sell  securities in the State.
     The  Company is  cooperating  with the  State's  inquiry,  and is unable to
     speculate at this time as to the outcome of such inquiry. All LLC interests
     sold in the State of Florida are approximately $1,472,000.

     The  Company  has been  notified  of three  separate  law suits by  various
     lenders and vendors demanding,  among other things, return of principle and
     interest. There has also been a suite filed by one LLC investor.


(4)  CONTINGENCY

     At December 31, 1999, the Company has suffered  recurring  losses and has a
     net capital  deficiency of $3,849,538 and a working  capital  deficiency of
     $4,132,944, which raises substantial doubt about its ability to continue as
     a going concern.  Loss have  continued,  although at a slower rate, and are
     expected  to  continue  for  the  balance  of  the  year.  The  Company  is
     contemplating  a public or private  offering  of  securities  as a means of
     raising funds to implement its business plan.


                                        3
<PAGE>
(5)  SUBSEQUENT  EVENTS

     ACCESS  HEATHCARE

     The Company agreed to acquire Access HealthCare,  Inc.  (Healthcare) during
     1999,   subject  to  certain   conditions   including   the   financing  of
     Alternatives.  Under the terms of the acquisition, to be accounted for as a
     pooling of  interests,  the Company will exchange  shares  of  common stock
     for  all  of  HealthCare's  outstanding  shares.   HealthCare   operates  a
     chiropractic  group  practice  in  Central   Florida   and  has  affiliated
      chiropractic practices throughout Florida.

     If the  acquisition is consummated,  the financial  position and results of
     operations  of  the  Company  and  HealthCare  will  be  combined  in  2000
     retroactive  to January 1, 2000. In addition,  all prior periods  presented
     will be restated to give effect to the pooling.

     Presented below are condensed combined pro forma financial statements as of
     and for the nine month  period  ended September 30,  2000 to give effect to
     the transaction.  The  condensed  combined financial statements reflect the
     elimination of intercompany transactions.


<TABLE>
<CAPTION>
     Condensed balance sheet at September 30, 2000:

                                       COMPANY      HEALTHCARE    ELIMINATIONS    COMBINED
                                     ------------  ------------  --------------  -----------
<S>                                  <C>           <C>           <C>             <C>
Assets:
  Current assets                     $   194,194   $   289,127                   $  483,321
  Property & equipment, net               36,441        72,295                      108,736
  Other assets                             5,051        26,527         (26,316)       5,262
  Deferred rescission costs              640,663                                    640,663
                                     ------------  ------------  --------------  -----------

                                     $   876,349   $   387,949   $     (26,316)  $ 1,237,982
                                     ============  ============  ==============  ===========

Liabilities:
  Current liabilities                $ 4,976,117   $   475,758   $     (26,316)  $ 5,425,559
  Unearned income                        196,694                                    196,694
  Long-term obligations                   12,594       100,169                      112,763
  Minority interest                      129,545                                    129,545
                                     ------------  ------------  --------------  -----------

                                       5,314,950       575,927         (26,316)    5,864,561
  Stockholders' deficit               (4,438,601)     (187,978)                  (4,710,633)
                                     ------------  ------------  --------------  -----------

                                     $   876,349   $   387,949   $     (26,316)  $ 1,283,472
                                     ------------  ------------  --------------  -----------

Condensed statement of operations:

Revenues                             $   196,122   $ 1,617,534   $     (27,510)  $ 1,786,146
Operating costs and expenses             848,174     1,469,405         (27,510)  $ 2,290,069
                                     ------------  ------------  --------------  -----------

Operating income (loss)                 (652,052)      148,129                     (503,923)
Other expenses                          (187,015)                                  (187,015)
                                     ------------  ------------  --------------  -----------

Net income (loss)                    $  (839,067)  $   148,129                   $ (690,938)
                                     ============  ============  ==============  ===========

Basic net loss per share                                                         $    (0.22)
                                                                                 ===========
</TABLE>


                                        4
<PAGE>
ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

     The  following  discussion  and analysis should be read in conjunction with
the  financial  statements  of  the Company and the accompanying notes appearing
previously  under  the  caption "Financial Statements." The following discussion
and  analysis  contains  forward-looking  statements,  which  involve  risks and
uncertainties.  The  Company's  actual results may differ significantly from the
results,  expectations  and plans discussed in these forward-looking statements.

Results  of  Operations  for  the  Period Ended September 30, 2000 compared with
Period  Ended  September  30,  1999:

     Management  believes  that a comparison of the financial performance of the
Company in the nine months ended September 30, 2000 and in the nine months ended
September  30,  1999  clearly  shows  the  continued impact of a lack of capital
necessary  to grow the operations. The impact of the capital shortfall continues
to  share  the  attention  of  Senior Management with the demands of the ongoing
operations.

     During  the  nine  months  represented, the Company completed it's plans to
down  size  its  operations and reduce overhead in order to accommodate the cash
shortfall.  Certain  operations and development activities were suspended unless
and  until  new capital is raised.  The resulting impact to Total Revenues was a
decline of 64.1% in 2000 dropping to $196,122 from $546,583 in the previous nine
month  period.  This  Revenue figure decline in the third quarter as compared to
the  same period in 1999 was $152,695 which is a decline of only $4,470 from the
previous  quarter.  It  is anticipated that the company is now at a base revenue
level  and  further  revenue  declines  from  a quarter to quarter basis will be
minimal.  Marketing  activities  during  the  nine  months  continued to revolve
around  limited  direct  mail  to  current  and past customers and promotions of
specific  products.  There  has  been  a  decline in the provider network as all
regional  sales  and support activities were suspended other than in the Central
Florida  market.  Sales  and  support activity is currently being handled by the
corporate  staff  in  Orlando.

     Selling,  general and administrative expenses declined 57.7% as compared to
the  previous  nine  months  and  reflects the efforts taken to reduce operating
expenses.  This  expense  category  is  higher then the previous quarter due, in
part,  to expenses related to the settlement with a former officer and director.
Interest  expense increased over the previous nine month period by $82,251 which
is  principally  related  to  restatement  of  interest for loans from a related
party.

Liquidity  and  Capital  Resources

     Continued cash flow shortages have slowed the Company's growth and diverted
management's  attention  away  from  its aggressive development activities.  The
Company  has  experienced  a  rise  in  accounts payable and accrued liabilities
directly attributable to the cash shortfall.  Current liabilities increased from
$4,342,254  at  the  beginning  of the year to %4,976,117, or 12.7%. The Company
continues  to  rely  on  loans from affiliated and unaffiliated parties to cover
some  of  its  cash  flow  shortfall.  As  evidence,  Notes Payable increased by
$43,277 during the third quarter to $1,617,128. Loans from Access Healthcare, an
announced  acquisition,  increased  by  $109,557  during  the  quarter.


<PAGE>
     Accounts  receivable  and  other  current  and  long-term  assets  remained
relatively  unchanged  other  then  a  reduction  in Inventory of $6,888 for the
quarter  and  $29,968  for  the  nine  month  period reflecting sales during the
period(s).  Total  asset  decline is explained by the reduction in Inventory and
depreciation of property and equipment.  There were no purchases or disposals of
assets  during  the  period(s)  other  than  in  the  normal course of business.

     The  cash  used  in operations for the nine months ended September 31, 2000
and  1999  was  $336,795  and  $583,029,  respectively.

     The Company continues to experience negative cash flow and anticipates this
continuing through the end of the current fiscal year.  Management believes that
additional  funding  will  be  necessary  in order for it to continue as a going
concern.  As stated in previous filings, management is actively pursuing various
options  including the private placement of Preferred and or Common stock, and a
possible  secondary  public  offering  of  the  Companies  Common  stock


                           PART  II  -  OTHER  INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS.

     As  previously disclosed Access HealthMax, Inc. has been named as defendant
in  four  law suits.  These have been brought on behalf of a vendor, two lenders
and an investor in a Limited Liability Company for which Access HealthMax is the
general  partner.  All  suits  remain  outstanding  and  the company has engaged
appropriate  legal  representation.

ITEM  2.  CHANGES  IN  SECURITIES

     The  following  activity took place during the quarter ending September 30,
2000.

     The  Company  issued 100,000 common shares each to Donald Metchick pursuant
to  a  settlement  agreement  for  all  amounts  owed  and unpaid to this former
Director  and  Officer,  pursuant to Section 4(2) of the Securities and Exchange
Act  of  1933.

     The  Company issued 100,000 common shares each to Donald Metchick, a former
Director  and  Officer,  and  Steven  Miracle,  a  current Director and Officer,
related  to  certain  employment agreements.  Such shares were earned in January
2000 and were issued pursuant to Section 4(2) of the Securities and Exchange Act
of  1933.

     The Company issued a total of 140,000 common shares, to various individuals
relative  to direct investments made in the Company, pursuant to Section 4(2) of
the  Securities  and  Exchange  Act  of  1933.

     The Company issued 26,666 share to an individual who had previously made an
investment in the company's "Market License" program.  The shares were issued in
return  for  converting  the Market License interest into shares of the Company.
The  conversion was made pursuant to Section 4(2) of the Securities and Exchange
Act  of  1933.

ITEM  3.  DEFAULTS  UPON  SENIOR  SECURITIES

Access HealthMax, Inc. continues to be in default of is loan agreements and will
be  unable  to  pay  interest  and  principle until new capital has been raised.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

n/a

ITEM  5.  OTHER  INFORMATION.

     The  company  reached a settlement with a former Officer and Director which
has  been  previously  disclosed.

ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

     On  August 31, 2000 the Company filed an 8-K relative to the resignation of
an  Officer  and  Director

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the Company caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.


                                   ACCESS  HEALTH  ALTERNATIVES,  INC.
                                   -----------------------------------
                                              (registrant)



     Date:  11/19/00                     /s/  Daniel  J.  Pavlik
            --------                     ---------------------------------------
                                                       (signature)*
                                         Daniel  J.  Pavlik,  President  &  CEO



     Date:  11/19/00                     /s/  Steven  Miracle
            --------                     ---------------------------------------
                                                       (signature)*
                                         Steven Miracle, Chief Operating Officer


<PAGE>